|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu J, Li Q, He JT and Liu GY: Expression
of TAK1/TAB1 expression in non-small cell lung carcinoma and
adjacent normal tissues and their clinical significance. Int J Clin
Exp Pathol. 8:15801–15807. 2015.PubMed/NCBI
|
|
3
|
Szakacs G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta N, Hatoum H and Dy GK: First line
treatment of advanced non-small-cell lung cancer-specific focus on
albumin bound paclitaxel. Int J Nanomedicine. 9:209–221.
2014.PubMed/NCBI
|
|
5
|
Zhou Z, Kennell C, Lee JY, Leung YK and
Tarapore P: Calcium phosphate-polymer hybrid nanoparticles for
enhanced triple negative breast cancer treatment via co-delivery of
paclitaxel and miR-221/222 inhibitors. Nanomedicine. 13:403–410.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fushida S, Kinoshita J, Kaji M, Oyama K,
Hirono Y, Tsukada T, Fujimura T and Ohta T: Paclitaxel plus
valproic acid versus paclitaxel alone as second- or third-line
therapy for advanced gastric cancer: A randomized Phase II trial.
Drug Des Devel Ther. 10:2353–2358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Horwitz SB, Cohen D, Rao S, Ringel I, Shen
HJ and Yang CP: Taxol: Mechanisms of action and resistance. J Natl
Cancer Inst Monogr. 55–61. 1993.PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tufekci KU, Oner MG, Meuwissen RL and Genc
S: The role of microRNAs in human diseases. Methods Mol Biol.
1107:33–50. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Milagro FI, Miranda J, Portillo MP,
Fernandez-Quintela A, Campion J and Martinez JA: High-throughput
sequencing of microRNAs in peripheral blood mononuclear cells:
Identification of potential weight loss biomarkers. PLoS One.
8:e543192013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Genovesi LA, Carter KW, Gottardo NG, Giles
KM and Dallas PB: Integrated analysis of miRNA and mRNA expression
in childhood medulloblastoma compared with neural stem cells. PLoS
One. 6:e239352011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang C, Feng Z, Jiang K and Zuo X:
Upregulation of MicroRNA-935 promotes the malignant behaviors of
pancreatic carcinoma PANC-1 cells via targeting inositol
polyphosphate 4-phosphatase type I gene (INPP4A). Oncol Res.
25:559–569. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang M, Cui G, Ding M, Yang W, Liu Y, Dai
D and Chen L: miR-935 promotes gastric cancer cell proliferation by
targeting SOX7. Biomed Pharmacother. 79:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Li J, Yu Z, Li J, Sun R and Kan Q:
miR-935 promotes liver cancer cell proliferation and migration by
targeting SOX7. Oncol Res. 25:427–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stovall DB, Cao P and Sui G: SOX7: From a
developmental regulator to an emerging tumor suppressor. Histol
Histopathol. 29:439–445. 2014.PubMed/NCBI
|
|
17
|
Cui J, Xi H, Cai A, Bian S, Wei B and Chen
L: Decreased expression of Sox7 correlates with the upregulation of
the Wnt/β-catenin signaling pathway and the poor survival of
gastric cancer patients. Int J Mol Med. 34:197–204. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li B, Ge Z, Song S, Zhang S, Yan H, Huang
B and Zhang Y: Decreased expression of SOX7 is correlated with poor
prognosis in lung adenocarcinoma patients. Pathol Oncol Res.
18:1039–1045. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo L, Zhong D, Lau S, Liu X, Dong XY, Sun
X, Yang VW, Vertino PM, Moreno CS, Varma V, et al: Sox7 Is an
independent checkpoint for beta-catenin function in prostate and
colon epithelial cells. Mol Cancer Res. 6:1421–1430. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng Z, Liu J, Yang Z, Wu L, Xie H, Jiang
C, Lin B, Chen T, Xing C, Liu Z, et al: MicroRNA-452 promotes
stem-like cells of hepatocellular carcinoma by inhibiting Sox7
involving Wnt/β-catenin signaling pathway. Oncotarget.
7:28000–28012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baselga J: Targeting the
phosphoinositide-3 (PI3) kinase pathway in breast cancer.
Oncologist. 16 Suppl 1:S12–S19. 2011. View Article : Google Scholar
|
|
24
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
